Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionlow-density lipoprotein particle receptor activity

LRP1 STAB1

4.16e-0416382GO:0005041
GeneOntologyMolecularFunctionlipoprotein particle receptor activity

LRP1 STAB1

7.24e-0421382GO:0030228
GeneOntologyMolecularFunctionacyltransferase activity, transferring groups other than amino-acyl groups

CRLS1 ZDHHC19 PHF10 ESCO1

1.06e-03238384GO:0016747
GeneOntologyMolecularFunctionscavenger receptor activity

LRP1 STAB1

1.20e-0327382GO:0005044
GeneOntologyMolecularFunctionretinoic acid binding

UGT1A9 UGT1A10

1.29e-0328382GO:0001972
GeneOntologyMolecularFunctionglucuronosyltransferase activity

UGT1A9 UGT1A10

2.02e-0335382GO:0015020
GeneOntologyMolecularFunctionATP-dependent chromatin remodeler activity

CHD3 CHD5

2.25e-0337382GO:0140658
GeneOntologyBiologicalProcessestrogen catabolic process

UGT1A9 UGT1A10

3.29e-055382GO:0006711
GeneOntologyBiologicalProcessphenylpropanoid catabolic process

UGT1A9 UGT1A10

4.93e-056382GO:0046271
GeneOntologyBiologicalProcesscoumarin catabolic process

UGT1A9 UGT1A10

4.93e-056382GO:0046226
GeneOntologyBiologicalProcessflavone metabolic process

UGT1A9 UGT1A10

4.93e-056382GO:0051552
GeneOntologyBiologicalProcessphenylpropanoid metabolic process

UGT1A9 UGT1A10

1.47e-0410382GO:0009698
GeneOntologyBiologicalProcesscoumarin metabolic process

UGT1A9 UGT1A10

1.47e-0410382GO:0009804
GeneOntologyBiologicalProcessflavonoid metabolic process

UGT1A9 UGT1A10

2.55e-0413382GO:0009812
GeneOntologyCellularComponentNuRD complex

CHD3 CHD5

4.53e-0417392GO:0016581
GeneOntologyCellularComponentCHD-type complex

CHD3 CHD5

4.53e-0417392GO:0090545
GeneOntologyCellularComponentSWI/SNF superfamily-type complex

CHD3 PHF10 CHD5

7.61e-0496393GO:0070603
DomainVWC

CCN5 FCGBP MUC5AC PXDNL

1.14e-0638394SM00214
DomainVWF_dom

CCN5 FCGBP MUC5AC PXDNL

1.72e-0642394IPR001007
DomainCHDCT2

CHD3 CHD5

1.27e-053392PF08074
DomainCHDNT

CHD3 CHD5

1.27e-053392PF08073
DomainDUF1086

CHD3 CHD5

1.27e-053392IPR009462
DomainDUF1087

CHD3 CHD5

1.27e-053392IPR009463
DomainDUF1087

CHD3 CHD5

1.27e-053392PF06465
DomainDUF1086

CHD3 CHD5

1.27e-053392PF06461
DomainDUF1087

CHD3 CHD5

1.27e-053392SM01147
DomainDUF1086

CHD3 CHD5

1.27e-053392SM01146
DomainCHD_N

CHD3 CHD5

1.27e-053392IPR012958
DomainCHD_C2

CHD3 CHD5

1.27e-053392IPR012957
DomainVWC

CCN5 MUC5AC PXDNL

2.66e-0528393PF00093
DomainVWFC_1

CCN5 MUC5AC PXDNL

5.73e-0536393PS01208
DomainVWFC_2

CCN5 MUC5AC PXDNL

6.75e-0538393PS50184
DomainEGF

LRP1 FCGBP PGAP6 SVEP1 STAB1

1.23e-04235395SM00181
DomainEGF-like_dom

LRP1 FCGBP PGAP6 SVEP1 STAB1

1.61e-04249395IPR000742
Domain-

SVEP1 STAB1

2.31e-04113922.40.155.10
DomainGFP-like

SVEP1 STAB1

2.31e-0411392IPR023413
DomainTIL

FCGBP MUC5AC

2.77e-0412392PF01826
DomainC8

FCGBP MUC5AC

2.77e-0412392PF08742
DomainGrowth_fac_rcpt_

LRP1 CCN5 SVEP1 STAB1

3.07e-04156394IPR009030
DomainUnchr_dom_Cys-rich

FCGBP MUC5AC

3.27e-0413392IPR014853
DomainC8

FCGBP MUC5AC

3.27e-0413392SM00832
DomainTIL_dom

FCGBP MUC5AC

3.81e-0414392IPR002919
DomainVWFD

FCGBP MUC5AC

5.01e-0416392PS51233
DomainVWD

FCGBP MUC5AC

5.01e-0416392SM00216
DomainVWF_type-D

FCGBP MUC5AC

5.01e-0416392IPR001846
DomainVWD

FCGBP MUC5AC

5.01e-0416392PF00094
DomainPHD

CHD3 PHF10 CHD5

5.12e-0475393PF00628
DomainZnf_PHD-finger

CHD3 PHF10 CHD5

5.96e-0479393IPR019787
DomainVWC_out

FCGBP MUC5AC

7.10e-0419392SM00215
DomainPHD

CHD3 PHF10 CHD5

8.44e-0489393SM00249
DomainH2B

H2BC20P H2BC19P

8.70e-0421392SM00427
DomainHISTONE_H2B

H2BC20P H2BC19P

8.70e-0421392PS00357
DomainHistone_H2B

H2BC20P H2BC19P

8.70e-0421392IPR000558
DomainUDPGT

UGT1A9 UGT1A10

8.70e-0421392PS00375
DomainUDPGT

UGT1A9 UGT1A10

8.70e-0421392PF00201
DomainUDP_glucos_trans

UGT1A9 UGT1A10

8.70e-0421392IPR002213
DomainZnf_PHD

CHD3 PHF10 CHD5

9.01e-0491393IPR001965
DomainZF_PHD_2

CHD3 PHF10 CHD5

1.02e-0395393PS50016
DomainZF_PHD_1

CHD3 PHF10 CHD5

1.05e-0396393PS01359
DomainChromo_domain

CHD3 CHD5

1.14e-0324392IPR023780
DomainChromo

CHD3 CHD5

1.34e-0326392PF00385
DomainEGF_3

LRP1 PGAP6 SVEP1 STAB1

1.42e-03235394PS50026
DomainCHROMO_2

CHD3 CHD5

1.55e-0328392PS50013
DomainCHROMO_1

CHD3 CHD5

1.55e-0328392PS00598
DomainEGF_1

LRP1 PGAP6 SVEP1 STAB1

1.92e-03255394PS00022
DomainSNF2_N

CHD3 CHD5

2.03e-0332392PF00176
DomainSNF2_N

CHD3 CHD5

2.03e-0332392IPR000330
DomainChromodomain-like

CHD3 CHD5

2.03e-0332392IPR016197
DomainEGF-like_CS

LRP1 PGAP6 SVEP1 STAB1

2.09e-03261394IPR013032
DomainEGF_CA

LRP1 SVEP1 STAB1

2.09e-03122393SM00179
DomainCHROMO

CHD3 CHD5

2.15e-0333392SM00298
DomainChromo/shadow_dom

CHD3 CHD5

2.15e-0333392IPR000953
DomainEGF-like_Ca-bd_dom

LRP1 SVEP1 STAB1

2.19e-03124393IPR001881
DomainEGF_2

LRP1 PGAP6 SVEP1 STAB1

2.21e-03265394PS01186
DomainEGF

LRP1 SVEP1 STAB1

2.29e-03126393PF00008
DomainDNA/RNA_helicase_DEAH_CS

CHD3 CHD5

2.42e-0335392IPR002464
DomainDEAH_ATP_HELICASE

CHD3 CHD5

2.85e-0338392PS00690
DomainZnf_FYVE_PHD

CHD3 PHF10 CHD5

3.55e-03147393IPR011011
Domain-

CHD3 CHD5

5.88e-03553921.10.30.10
DomainHistone

H2BC20P H2BC19P

6.09e-0356392PF00125
DomainHistone_H2A/H2B/H3

H2BC20P H2BC19P

6.09e-0356392IPR007125
PathwayWP_IRINOTECAN_PATHWAY

UGT1A9 UGT1A10

2.13e-0412262M39611
PathwayWP_CODEINE_AND_MORPHINE_METABOLISM

UGT1A9 UGT1A10

2.94e-0414262M39328
PathwayWP_ESTROGEN_METABOLISM_WP697

UGT1A9 ARSL

4.91e-0418262M39424
PathwayWP_ESTROGEN_METABOLISM

UGT1A9 UGT1A10

7.39e-0422262MM15888
PathwayREACTOME_GLUCURONIDATION

UGT1A9 UGT1A10

8.81e-0424262MM14599
PathwayWP_GLUCURONIDATION

UGT1A9 UGT1A10

9.56e-0425262MM15820
PathwayREACTOME_GLUCURONIDATION

UGT1A9 UGT1A10

9.56e-0425262M17787
PathwayKEGG_ASCORBATE_AND_ALDARATE_METABOLISM

UGT1A9 UGT1A10

9.56e-0425262M605
PathwayWP_GLUCURONIDATION

UGT1A9 UGT1A10

1.03e-0326262M39404
PathwayKEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS

UGT1A9 UGT1A10

1.20e-0328262M19580
PathwayREACTOME_PARACETAMOL_ADME

UGT1A9 UGT1A10

1.29e-0329262M45015
PathwayREACTOME_PARACETAMOL_ADME

UGT1A9 UGT1A10

2.32e-0339262MM15695
PathwayKEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM

UGT1A9 UGT1A10

2.57e-0341262M7399
Pubmed

Identification of UDP-glucuronosyltransferases responsible for the glucuronidation of darexaban, an oral factor Xa inhibitor, in human liver and intestine.

UGT1A9 UGT1A10

1.36e-06241222031623
Pubmed

Differences in the glucuronidation of bisphenols F and S between two homologous human UGT enzymes, 1A9 and 1A10.

UGT1A9 UGT1A10

1.36e-06241225547628
Pubmed

How many and which amino acids are responsible for the large activity differences between the highly homologous UDP-glucuronosyltransferases (UGT) 1A9 and UGT1A10?

UGT1A9 UGT1A10

1.36e-06241220089735
Pubmed

Cooperative Regulation of Intestinal UDP-Glucuronosyltransferases 1A8, -1A9, and 1A10 by CDX2 and HNF4α Is Mediated by a Novel Composite Regulatory Element.

UGT1A9 UGT1A10

4.06e-06341229519853
Pubmed

Glucuronidation of psilocin and 4-hydroxyindole by the human UDP-glucuronosyltransferases.

UGT1A9 UGT1A10

4.06e-06341220007669
Pubmed

Cloning and characterization of the human UDP-glucuronosyltransferase 1A8, 1A9, and 1A10 gene promoters: differential regulation through an interior-like region.

UGT1A9 UGT1A10

4.06e-06341212847094
Pubmed

Irinotecan pharmacokinetics/pharmacodynamics and UGT1A genetic polymorphisms in Japanese: roles of UGT1A1*6 and *28.

UGT1A9 UGT1A10

8.12e-06441217558305
Pubmed

Chromosomal mapping of a human phenol UDP-glucuronosyltransferase, GNT1.

UGT1A9 UGT1A10

8.12e-0644122108603
Pubmed

Variation of hepatic glucuronidation: Novel functional polymorphisms of the UDP-glucuronosyltransferase UGT1A4.

UGT1A9 UGT1A10

1.35e-05541215057901
Pubmed

Use of glucuronidation fingerprinting to describe and predict mono- and dihydroxyflavone metabolism by recombinant UGT isoforms and human intestinal and liver microsomes.

UGT1A9 UGT1A10

2.03e-05641220297805
Pubmed

Circadian Clock Component Rev-erbα Regulates Diurnal Rhythm of UDP-Glucuronosyltransferase 1a9 and Drug Glucuronidation in Mice.

UGT1A9 UGT1A10

2.03e-05641232527940
Pubmed

Birth-and-death long-term evolution promotes histone H2B variant diversification in the male germinal cell line.

H2BC20P H2BC19P

2.03e-05641220194426
Pubmed

Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37.

UGT1A9 UGT1A10

2.84e-0574128467709
Pubmed

Molecular cloning of two cDNAs encoding the mouse bilirubin/phenol family of UDP-glucuronosyltransferases (mUGTBr/p).

UGT1A9 UGT1A10

2.84e-0574128464825
Pubmed

Cyp3a11-mediated testosterone-6β-hydroxylation decreased, while UGT1a9-mediated propofol O-glucuronidation increased, in mice with diabetes mellitus.

UGT1A9 UGT1A10

2.84e-05741227514509
Pubmed

Assembly, verification, and initial annotation of the NIA mouse 7.4K cDNA clone set.

CCN5 WDFY4 ARHGEF10L RALGAPB

3.55e-0515741412466305
Pubmed

Oligomerization of the UDP-glucuronosyltransferase 1A proteins: homo- and heterodimerization analysis by fluorescence resonance energy transfer and co-immunoprecipitation.

UGT1A9 UGT1A10

3.78e-05841217179145
Pubmed

Alternatively spliced products of the UGT1A gene interact with the enzymatically active proteins to inhibit glucuronosyltransferase activity in vitro.

UGT1A9 UGT1A10

3.78e-05841220610558
Pubmed

Disposition of flavonoids via enteric recycling: enzyme stability affects characterization of prunetin glucuronidation across species, organs, and UGT isoforms.

UGT1A9 UGT1A10

3.78e-05841218052087
Pubmed

A genome-wide association study identifies UGT1A1 as a regulator of serum cell-free DNA in young adults: The Cardiovascular Risk in Young Finns Study.

UGT1A9 UGT1A10

4.86e-05941222511988
Pubmed

Family-based genome-wide association scan of attention-deficit/hyperactivity disorder.

UGT1A9 UGT1A10

4.86e-05941220732626
Pubmed

Association of SNPs in the UGT1A gene cluster with total bilirubin and mortality in the Diabetes Heart Study.

UGT1A9 UGT1A10

6.07e-051041223642732
Pubmed

UDP-glucuronosyltransferases.

UGT1A9 UGT1A10

6.07e-051041211465080
Pubmed

A genome-wide association study for serum bilirubin levels and gene-environment interaction in a Chinese population.

UGT1A9 UGT1A10

6.07e-051041223371916
Pubmed

A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia.

UGT1A9 UGT1A10

6.07e-051041222558097
Pubmed

Functional characterization of a human histone gene cluster duplication.

H2BC20P H2BC19P

7.41e-051141215527963
Pubmed

Local anesthetics impair the growth and self-renewal of glioblastoma stem cells by inhibiting ZDHHC15-mediated GP130 palmitoylation.

LRP1 MUC5AC CDCA7L

8.22e-057141333541421
Pubmed

Common variants in the SLCO1B3 locus are associated with bilirubin levels and unconjugated hyperbilirubinemia.

UGT1A9 UGT1A10

8.88e-051241219419973
Pubmed

Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans.

UGT1A9 UGT1A10

8.88e-051241220308471
Pubmed

Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus.

UGT1A9 UGT1A10

8.88e-051241211434514
Pubmed

Substrate and functional diversity of lysine acetylation revealed by a proteomics survey.

UGT1A9 H2BC20P H2BC19P UGT1A10

9.64e-0520341416916647
Pubmed

UGT1A1 is a major locus influencing bilirubin levels in African Americans.

UGT1A9 UGT1A10

1.05e-041341222085899
Pubmed

Genome-wide analysis of hepatic lipid content in extreme obesity.

UGT1A9 UGT1A10

1.05e-041341225246029
Pubmed

Discovery and refinement of loci associated with lipid levels.

LRP1 UGT1A9 UGT1A10 STAB1

1.12e-0421141424097068
Pubmed

Mayo Genome Consortia: a genotype-phenotype resource for genome-wide association studies with an application to the analysis of circulating bilirubin levels.

UGT1A9 UGT1A10

1.22e-041441221646302
Pubmed

Human UDP-glucuronosyltransferases: metabolism, expression, and disease.

UGT1A9 UGT1A10

1.22e-041441210836148
Pubmed

Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation.

UGT1A9 UGT1A10

1.22e-041441214672974
Pubmed

The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence.

UGT1A9 UGT1A10

1.22e-04144129295054
Pubmed

DLX1 and the NuRD complex cooperate in enhancer decommissioning and transcriptional repression.

CHD3 CHD5

1.41e-041541235695185
Pubmed

Genome-wide association meta-analysis for total serum bilirubin levels.

UGT1A9 UGT1A10

1.61e-041641219414484
Pubmed

Genome-wide association of serum bilirubin levels in Korean population.

UGT1A9 UGT1A10

1.82e-041741220639394
Pubmed

A Functional Switch of NuRD Chromatin Remodeling Complex Subunits Regulates Mouse Cortical Development.

CHD3 CHD5

1.82e-041741227806305
Pubmed

Inhibition of core histones acetylation by carcinogenic nickel(II).

H2BC20P H2BC19P

2.05e-041841216283522
Pubmed

Phase II metabolism of hesperetin by individual UDP-glucuronosyltransferases and sulfotransferases and rat and human tissue samples.

UGT1A9 UGT1A10

2.05e-041841220056724
Pubmed

Apoptotic phosphorylation of histone H2B is mediated by mammalian sterile twenty kinase.

H2BC20P H2BC19P

2.05e-041841212757711
Pubmed

Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.

CHD3 H2BC20P ZNF831 AHDC1 CDCA7L

2.19e-0446941527634302
Pubmed

A genome-wide assessment of variability in human serum metabolism.

UGT1A9 UGT1A10

2.29e-041941223281178
Pubmed

Prediction of the coding sequences of unidentified human genes. XVIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.

OBSCN WDFY4 ARHGEF10L

2.34e-0410141310997877
Pubmed

NuRD subunit CHD4 regulates super-enhancer accessibility in rhabdomyosarcoma and represents a general tumor dependency.

CHD3 H2BC20P CHD5

2.48e-0410341332744500
Pubmed

Genetic determinants influencing human serum metabolome among African Americans.

UGT1A9 UGT1A10

3.68e-042441224625756
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

WDR90 SERINC1 CHD5 ARHGEF10L STAB1

3.81e-0452941514621295
Pubmed

Identification of the BRD1 interaction network and its impact on mental disorder risk.

CHD3 CHD5

7.87e-043541227142060
Pubmed

Cross-linking mass spectrometry reveals the structural topology of peripheral NuRD subunits relative to the core complex.

CHD3 CHD5

9.28e-043841233283408
Pubmed

Novel Cul3 binding proteins function to remodel E3 ligase complexes.

WDR90 WDFY4

1.03e-034041225011449
Pubmed

High-throughput analyses of hnRNP H1 dissects its multi-functional aspect.

OBSCN CHD3 PHF10 SERINC1 AHDC1 ARHGEF10L

1.18e-03102141626760575
Cytoband2q37

UGT1A9 UGT1A10

3.56e-04314122q37
Cytoband9q32

KIF12 SVEP1

8.20e-04474129q32
Cytoband1p36.13

AHDC1 ARHGEF10L

1.16e-03564121p36.13
Cytoband1q21.2

H2BC20P H2BC19P

1.86e-03714121q21.2
GeneFamilyPHD finger proteins|NuRD complex

CHD3 CHD5

1.62e-04122921305
GeneFamilyPHD finger proteins

CHD3 PHF10 CHD5

3.97e-049029388
GeneFamilyUDP glucuronosyltransferases

UGT1A9 UGT1A10

1.20e-0332292363
GeneFamilyPleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing

OBSCN ARHGEF10L

5.00e-0366292722
GeneFamilyHistones

H2BC20P H2BC19P

1.48e-02116292864
ToppCellmoderate-Epithelial-FOXN4+|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

ADGRB2 CCDC14 WDR90 PHF10 CDCA7L

9.35e-071944155dffa578149104dda33774361e9e77b227b5f1ce
ToppCellmoderate-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

ADGRB2 CCDC14 WDR90 PHF10 CDCA7L

9.35e-07194415dff3fb10372053951d41e0ccd41aac3ece6009bd
ToppCellE16.5-samps-Myeloid-Macrophage-CD163+_Macrophage|E16.5-samps / Age Group, Lineage, Cell class and subclass

UGT1A9 PGAP6 UGT1A10 CNR2

1.04e-0514841456e146980a71b5ca655118ae13310c5949220d4a
ToppCellE16.5-samps-Myeloid-Macrophage|E16.5-samps / Age Group, Lineage, Cell class and subclass

UGT1A9 PGAP6 UGT1A10 CNR2

1.04e-05148414cd5f697d8c2f272be1f3f52a05446749278431c5
ToppCell-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id

CCN5 PXDNL CNR2 ICAM3

1.63e-05166414bc9323de1373fdc0357e6bb46874f6c4787443a9
ToppCellCOVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type

OBSCN FCGBP WDFY4 STAB1

1.79e-051704144232fe937909f93d3736988c707b8f95ce993398
ToppCellmetastatic_Lymph_Node-Myeloid_cells-Microglia/Mac|metastatic_Lymph_Node / Location, Cell class and cell subclass

ZDHHC19 FCGBP MUC5AC STAB1

1.87e-05172414f673a2e697b46e7cfa4186cb3fb2b98e3c83703e
ToppCellmetastatic_Brain-Myeloid_cells-CD141+_DCs|Myeloid_cells / Location, Cell class and cell subclass

KIF12 WDFY4 CNR2 ICAM3

1.96e-051744145ec8a48a390379d6c422120dce46437a77da67cc
ToppCell10x5'-bone_marrow-Myeloid_Mac-Intestinal_macrophages|bone_marrow / Manually curated celltypes from each tissue

LRP1 FCGBP ARHGEF10L STAB1

1.96e-051744140746344d62aa7ab77c378e9d5a9f9238e741a76b
ToppCellfacs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ADGRB2 CHD3 ZNF831 CHD5

2.59e-05187414e04a84989d624378141042768383b9c846901f2d
ToppCellfacs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ADGRB2 CHD3 ZNF831 CHD5

2.59e-0518741424cc03c748e15f7ef0e6509ca5a6ca583fb9c573
ToppCellfacs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ADGRB2 CHD3 ZNF831 CHD5

2.59e-051874142f153b203fe79f206319603cf94d3a03ab49a05d
ToppCell(1)_B_cell|World / immune cells in Peripheral Blood (logTPM normalization)

ZDHHC19 WDFY4 CDCA7L CNR2

2.65e-05188414642a334f2d5b6dc9df4a9fa0558833bd37bd3c58
ToppCell(10)_B_cell|World / immune cells in Peripheral Blood (logTPM normalization)

ZDHHC19 WDFY4 CDCA7L CNR2

2.65e-05188414fa1346902021c3a6557555ada0fd37b29cf9d5ec
ToppCelltumor_Lymph_Node_/_Brain-B_lymphocytes|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass

ZDHHC19 WDFY4 CDCA7L CNR2

2.65e-05188414064a66cbca5648371d6360cfcb3965845a81c65f
ToppCell10x5'-GI_large-bowel-Myeloid_Monocytic|GI_large-bowel / Manually curated celltypes from each tissue

LRP1 FCGBP ARHGEF10L STAB1

2.65e-05188414d0045fdda757d191dabc7853f6a6e99c0e97d93d
ToppCell10x5'-GI_large-bowel-Myeloid_Monocytic-Classical_monocytes|GI_large-bowel / Manually curated celltypes from each tissue

LRP1 FCGBP ARHGEF10L STAB1

2.65e-051884140bcf04aa47738f43c1a87dae5dc487738ee86f8c
ToppCellNS-moderate-d_16-33-Epithelial-FOXN4+|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

ADGRB2 CCDC14 WDR90 CDCA7L

2.76e-05190414250ca4a605c1cccd77d23383e4fe6f91cf3609ba
ToppCellNS-critical-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

ADGRB2 CCDC14 PHF10 CDCA7L

2.76e-051904147be0f2ff86ca8500a43e0d44e5e292530f9ba0bb
ToppCell367C-Lymphocytic-B_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

ZDHHC19 WDFY4 CDCA7L CNR2

2.76e-05190414c34facacdbd093075d7f330168706e2cf525f5fc
ToppCell390C-Myeloid-Macrophage|390C / Donor, Lineage, Cell class and subclass (all cells)

LRP1 ZDHHC19 FCGBP ARHGEF10L

2.76e-05190414f933d971f092c4e56e9f670a9205b688c8b1ca28
ToppCell367C-Lymphocytic-B_cell-|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

ZDHHC19 WDFY4 CDCA7L CNR2

2.76e-051904143a0542bccf48f7b865f84363e1025072189275c4
ToppCelltumor_Lymph_Node_/_Brain-B_lymphocytes-Follicular_B_cells|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass

ZDHHC19 WDFY4 CDCA7L CNR2

2.82e-0519141406edf2e9b50ea20060648d41fa42ee16086fdf42
ToppCell(100)_CD19+_Naive_B_cell|World / immune cells in Peripheral Blood (logTPM normalization)

ZDHHC19 WDFY4 CDCA7L CNR2

2.88e-05192414ae7e6ed7b6cc1dd45bc0547783515beecad7792a
ToppCellCOVID-19-lung-Macrophage_CD163hi_MERTKhi|lung / Disease (COVID-19 only), tissue and cell type

LRP1 WDFY4 ARHGEF10L STAB1

3.06e-05195414148fff8c3c9ba45ec36e98dff1be57e3f8294506
ToppCellPBMC-Control-Lymphocyte-B-B_cell-B_naive|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

ZDHHC19 WDFY4 CDCA7L CNR2

3.12e-05196414fcbfd8c4771d99a45fc53e482ef98edabe8ef591
ToppCellPBMC-Control-Lymphocyte-B-B_cell-B_naive|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

ZDHHC19 WDFY4 CDCA7L CNR2

3.12e-05196414f45cb8f714ae7ac800768df65f299b98a2d42962
ToppCellPBMC-Control-Lymphocyte-B-B_cell-B_naive-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

ZDHHC19 WDFY4 CDCA7L CNR2

3.12e-05196414d7e6c89cb49933b4a86d26d15f6772f2481d37ef
ToppCellCOVID-19-lung-Macrophage_metabolically_active|lung / Disease (COVID-19 only), tissue and cell type

LRP1 WDFY4 ARHGEF10L STAB1

3.12e-05196414a753d76d764c181eecb0e17a794a2e7d0ff70136
ToppCell3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

LRP1 CCN5 PXDNL SVEP1

3.18e-0519741471786e9432e2d649f5d86f639abb25e7102deb67
ToppCellVE-mono1-|VE / Condition, Cell_class and T cell subcluster

LRP1 FCGBP ARHGEF10L STAB1

3.24e-051984142959d6e4992c36040ec9637f5a2daed02b35cf30
ToppCellcritical-Epithelial-FOXN4+|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

ADGRB2 CCDC14 PHF10 CDCA7L

3.24e-051984146b160b3d6a2c1b1641c2c7dcec1a7ef38411fec9
ToppCellVE-mono1|VE / Condition, Cell_class and T cell subcluster

LRP1 FCGBP ARHGEF10L STAB1

3.24e-05198414c742871b8ec4720b1848991551c7c1f4000ebd85
ToppCell3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

LRP1 CCN5 PXDNL SVEP1

3.31e-051994141fd7bbb8727607e6507848602a19bc86882ef2d5
ToppCell10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_macrophage-macrophage|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

LRP1 FCGBP ARHGEF10L STAB1

3.31e-05199414c0dcdda30485bb920d3706dcfb06f11b76b6ea37
ToppCell10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_macrophage|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

LRP1 FCGBP ARHGEF10L STAB1

3.31e-05199414b827dd8a249f904a0ff930a6c4d3b00fb7bc6fb1
ToppCell3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

LRP1 CCN5 PXDNL SVEP1

3.31e-051994149672230aa0bc6a7289050c955f5154ca183a5159
ToppCell3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

LRP1 CCN5 PXDNL SVEP1

3.31e-05199414e18abe678da293bd01fae55e2f9ab6fdd643d02d
ToppCellBAL-Severe-cDC_0|Severe / Compartment, Disease Groups and Clusters

LRP1 RHBDD2 ARHGEF10L STAB1

3.31e-05199414d39be8b173156bf87baddd3caed4b35597c53ea1
ToppCellCOVID-19-COVID-19_Mild-Lymphocyte-B-B_naive|COVID-19_Mild / Disease, condition lineage and cell class

ZDHHC19 WDFY4 CDCA7L CNR2

3.37e-05200414e6a43eff47195e1d39530ad49ad908fc06a8b038
ToppCellCOVID-mono1|COVID / Condition, Cell_class and T cell subcluster

LRP1 FCGBP ARHGEF10L STAB1

3.37e-05200414bd002c54305c746c07b7418a2084195e9c852ec5
ToppCellMS-Multiple_Sclerosis-Lymphocyte-B-B_naive|Multiple_Sclerosis / Disease, condition lineage and cell class

ZDHHC19 WDFY4 CDCA7L CNR2

3.37e-052004144d16545608aa4289a5e406512100c617ccee6a97
ToppCellMS-IIF-Lymphocyte-B|IIF / Disease, condition lineage and cell class

ZDHHC19 WDFY4 CDCA7L CNR2

3.37e-05200414a0f3362b7ddfc122e30e75fb541bb0b7d0321c72
ToppCellControl-Control-Lymphocyte-B-B_naive|Control / Disease, condition lineage and cell class

ZDHHC19 WDFY4 CDCA7L CNR2

3.37e-0520041415e4b9956b9a0c2e6927a802e86e1cb4bb18b89a
ToppCellCOVID-mono1-|COVID / Condition, Cell_class and T cell subcluster

LRP1 FCGBP ARHGEF10L STAB1

3.37e-05200414445a1aab962673dcc926c33ce9bed5ede9c41c57
ToppCellCOVID|World / Condition, Cell_class and T cell subcluster

LRP1 FCGBP ARHGEF10L STAB1

3.37e-0520041404a932fe2431e7886120c219ce666f90d3030a1c
ToppCellmild-B_naive|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

ZDHHC19 WDFY4 CDCA7L CNR2

3.37e-05200414d0467cab6a42bf780aa49046bf3231ca161dc144
ToppCellTCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-4|TCGA-Brain / Sample_Type by Project: Shred V9

KIF12 ZNF831 CHD5

2.53e-0413441304ee54e788f6659af0349be8c0ff991fcac2b2aa
ToppCellLPS-IL1RA-Myeloid-Monocytes,_Macrophages-Neutrophils|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

WDFY4 PGAP6 ARHGEF10L

2.82e-04139413505bf5a483fc2ba69377db9850c3b26ab2f416d1
ToppCell10x5'-Lung-Myeloid_Mac-Intestinal_macrophages|Lung / Manually curated celltypes from each tissue

FCGBP WDFY4 STAB1

2.94e-041414137671d300b1722711fd2d8034b96a3aa7e3ccb560
ToppCellHealthy-B_cell|World / disease group, cell group and cell class

ADGRB2 ZNF831 CNR2

3.26e-04146413588359d3df6ad7090b7fa6c7f8d29cc1717e7f4f
ToppCellPBMC-Control-Lymphocyte-B-B_cell-B_memory-B_memory-6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

WDFY4 CDCA7L CNR2

3.46e-041494132cd860b96ed4be4d26844085d464961c1418054a
ToppCell367C-Fibroblasts-Fibroblast-D-|367C / Donor, Lineage, Cell class and subclass (all cells)

LRP1 CCN5 SVEP1

3.81e-04154413dd3d34f065820e706515a13619f19a5b12734c8e
ToppCell367C-Fibroblasts-Fibroblast-D|367C / Donor, Lineage, Cell class and subclass (all cells)

LRP1 CCN5 SVEP1

3.81e-041544134bfda1c41efbb86d829b3797d1168bf2587c3c97
ToppCellfacs-Brain_Non-Myeloid-Hippocampus-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ADGRB2 CHD3 CHD5

3.88e-0415541372a19a9ecfd13f6769c4b447d3ce01a855ec6ec7
ToppCell5'-GW_trimst-1.5-SmallIntestine-Epithelial-epithelial_progenitor_cell-Distal_progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

KIF12 ARSL CNR2

4.11e-04158413ab707bfe782c667b252b488ad1d7efd49cf0a899
ToppCellPCW_05-06-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor1_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung

FCGBP WDFY4 STAB1

4.26e-041604137f1b58641ba149d20420fafad34ba78a65a2c701
ToppCellPBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-11|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

ZDHHC19 WDFY4 CDCA7L

4.26e-041604138396afbc7d919ba190863d50aa0ef8b9942a9866
ToppCellPND01-03-samps-Myeloid-Macrophage-CD163+_Macrophage|PND01-03-samps / Age Group, Lineage, Cell class and subclass

UGT1A9 ZNF831 WDFY4

4.26e-041604134480a7d6bd48d06b4e5196faac868f31ab7ed3ad
ToppCelldroplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TMEM65 CCDC14 WDFY4

4.50e-041634138dc0128eeede933537e3bcc5d6ec0322711552f3
ToppCellfacs-Marrow-T_cells-18m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LRP1 KIF12 ARHGEF10L

4.50e-0416341330cd95d4f37bd54c1fde54960cb005db58bdd30c
ToppCelldroplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TMEM65 CCDC14 WDFY4

4.50e-04163413fd243ca223079033be480a24817a399f281fa4d4
ToppCellfacs-Marrow-T_cells-18m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LRP1 KIF12 ARHGEF10L

4.50e-04163413ab934cb986495adfc8dbe5a276577f2a8fb6ee03
ToppCellAdult-Immune-dendritic_cell|Adult / Lineage, Cell type, age group and donor

WDFY4 CNR2 ICAM3

4.66e-04165413073f52698dac1fe4edd7410865f81b30e1c7196a
ToppCellPBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

WDFY4 CDCA7L CNR2

4.66e-04165413fead3f2032f8fa5f7f0159a4434989b3d65debbb
ToppCellnormal_Lymph_Node-Myeloid_cells-CD141+_DCs|Myeloid_cells / Location, Cell class and cell subclass

WDFY4 CNR2 ICAM3

4.74e-041664136210a136efb99d70c2026b6454363f1bd2723558
ToppCellfacs-Heart-RV-24m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LRP1 UGT1A9 SVEP1

4.83e-041674133e3d8f6df2feefafad5b44ba0ebf5b5a0fe4ed58
ToppCellfacs-Heart-RV-24m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LRP1 UGT1A9 SVEP1

4.83e-041674133ad9f3122dbe96580f640388ef920ea209fc2349
ToppCellmild-Lymphocytic-B_cells_2|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

WDFY4 CDCA7L CNR2

4.83e-041674130811f7559c2a7151693771e52e14af3978997118
ToppCellmetastatic_Lymph_Node-Myeloid_cells-Microglia/Mac|Myeloid_cells / Location, Cell class and cell subclass

ZDHHC19 MUC5AC ABHD17C

5.00e-04169413dba8f5599aa21feef5b7fdfed2e3ab54748d80f7
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c3-EREG|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

LRP1 WDFY4 STAB1

5.08e-041704139ac1ef57f14418a5dd2aa16861c3df698c28f5ed
ToppCelldroplet-Spleen-nan-21m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LRP1 FCGBP ARHGEF10L

5.08e-0417041303cb4e508356f85372a588c8d1c6babf2a012683
ToppCelldroplet-Spleen-nan-21m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LRP1 FCGBP ARHGEF10L

5.17e-041714139498c35b2a2c3a339dc8c5d49c8ec20d8ad52753
ToppCell3'-Distal_airway-Immune_Myeloid-Dendritic-conventional_dendritic_cell-DC1_(conventional_dendritic_cell)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

WDFY4 CNR2 ICAM3

5.17e-041714131018d7bd378ce20bee56a77d5851b3538c55098c
ToppCelldroplet-Spleen-nan-21m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LRP1 FCGBP ARHGEF10L

5.17e-04171413db544252f98e073e5bb4bec4a110cd58e6434435
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

ZDHHC19 WDFY4 CDCA7L

5.17e-04171413c3e3ea09c73050372314a89b282e36ba5f339d73
ToppCell3'-Distal_airway-Immune_Myeloid-Dendritic-conventional_dendritic_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

WDFY4 CNR2 ICAM3

5.17e-04171413173bb5318fdbaef6e695b6f9e3e0ff4a5432a1a4
ToppCell3'-Distal_airway-Immune_Myeloid-Dendritic-conventional_dendritic_cell-DC1_(conventional_dendritic_cell)-DC1_L.1.2.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

WDFY4 CNR2 ICAM3

5.17e-041714136bda333bb751d7835a04f21ac959eea79f2516aa
ToppCellmetastatic_Brain-Myeloid_cells-CD207+CD1a+_LCs|Myeloid_cells / Location, Cell class and cell subclass

SPRY3 FCGBP ICAM3

5.26e-0417241338d17e769fe8eac8b57b820490d4ddd969243ee7
ToppCellfacs-Lung-EPCAM-24m-Lymphocytic-lymphocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CHD3 WDR90 ARHGEF10L

5.35e-041734136e92983d9f8a2a37f23e60a0d5bb1738217897bc
ToppCell3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-Goblet_(subsegmental)_L.0.4.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

FCGBP MUC5AC CNR2

5.35e-04173413e4d9a9a781acc531bc81c3fcee24d637e805c8e1
ToppCellfacs-Lung-EPCAM-24m-Lymphocytic-Alox5+_Lymphocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CHD3 WDR90 ARHGEF10L

5.35e-041734134c788c1dad1da495b3b5c10f95e779848dfe85dc
ToppCellfacs-Brain_Non-Myeloid-Cerebellum-3m-Lymphocytic-T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FCGBP CDCA7L CNR2

5.35e-041734137c5e4809205ce1a0a301c15442af00a2e2b9b301
ToppCellkidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

LRP1 CCN5 SVEP1

5.44e-041744139c916af5eebd932f67dc9117e1d26ff194a2ff2c
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-B_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ZNF831 WDFY4 CNR2

5.44e-041744131b2a2129c08bac01fc638692313b196759a1e0d7
ToppCellkidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

LRP1 CCN5 SVEP1

5.44e-04174413bc71521f44a5fe013af42b06b5d1bd2446ecf3b5
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-B_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ZNF831 WDFY4 CNR2

5.44e-041744135bde24eb588dc588efc413811379548120ec0c7f
ToppCellPBMC-Mild-Lymphocyte-B-B_cell-B_memory-B_memory-6|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

WDFY4 CDCA7L CNR2

5.53e-041754131b3510e9078eec7cfc5805043e435e9e5e0f0877
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Classical_Monocyte-Mono_c1-CD14-CCL3|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)

LRP1 CRLS1 STAB1

5.53e-041754135a29323d4a848ea544cdd78a0a4b73f9c122dc5e
ToppCellPBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

WDFY4 CDCA7L CNR2

5.62e-04176413ad05dd934f4ac2e656b3455de091f4c8772de6c8
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

LRP1 FCGBP STAB1

5.72e-04177413382f0d6bbff01e84b0c7840e74ac865864e6da89
ToppCell356C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)

SPRY3 FCGBP MUC5AC

5.72e-04177413709235694cc711b9b79690e23c94577b2ae06811
ToppCelldroplet-Marrow-BM-1m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TMEM65 LRP1 ARHGEF10L

5.72e-0417741326bad614560609d318bfc9c235a698bca4e1c22c
ToppCell356C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)

SPRY3 FCGBP MUC5AC

5.72e-041774137f9c2a45a994b32f15e5693f7cb873716a4eb568
ToppCell3'-GW_trimst-1.5-SmallIntestine-Epithelial-mature_enterocytic-Paneth|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

FCGBP ARSL MUC5AC

5.72e-041774132af09028014f4ec3b7d2a4c286f1ae5e84a9f590
ToppCellPBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-0|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

WDFY4 CDCA7L CNR2

5.81e-04178413be1d991c5a0a5be22f14f57d34ee1330f1a12963
ToppCell15-Trachea-Epithelial-Goblet-like_secretory|Trachea / Age, Tissue, Lineage and Cell class

FCGBP MUC5AC ABHD17C

5.81e-04178413f0557920b9b3e7c4f39938d1b524aa58711af4d2
ToppCellControl-Lymphocyte-B-B_naive|Control / Disease, Lineage and Cell Type

ZDHHC19 CDCA7L CNR2

5.91e-0417941335994281904bfe38766e715ab608211a5ca865a9
ToppCellnucseq-Epithelial-Epithelial_Glandular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

UGT1A9 FCGBP MUC5AC

5.91e-04179413859cd8ee414ad6207c046ada2e655e49322dd01c
ToppCellLPS_only-Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

LRP1 WDFY4 ARHGEF10L

5.91e-04179413dc03b9045510eb1bb934329646bb92dd06890ce9
DrugWoodward's reagent K

UGT1A9 ARSL UGT1A10 CNR2

8.64e-0743394CID000077804
Drugprostaglandin B1

UGT1A9 UGT1A10

1.71e-054392ctd:C034467
Drugnaringenin chalcone

UGT1A9 UGT1A10

2.85e-055392ctd:C027329
Druganthrarobin

UGT1A9 UGT1A10

2.85e-055392ctd:C032186
Drugalloin

UGT1A9 UGT1A10

4.27e-056392ctd:C006457
Drug1,2,5,8-tetrahydroxy anthraquinone

UGT1A9 UGT1A10

4.27e-056392ctd:C543211
Drug2',5'-dihydroxychalcone

UGT1A9 UGT1A10

4.27e-056392ctd:C107497
Drug2',4'-dihydroxychalcone

UGT1A9 UGT1A10

5.97e-057392ctd:C059354
Drugglabridin

UGT1A9 UGT1A10

7.95e-058392ctd:C107601
Drug1,4-dihydroxyanthraquinone

UGT1A9 UGT1A10

7.95e-058392ctd:C034890
DrugAC1L1G0K

UGT1A9 UGT1A10 CNR2

8.11e-0549393CID000003473
DrugAC1MRQNQ

UGT1A9 UGT1A10

1.02e-049392CID003522271
DrugDHPASiU

UGT1A9 UGT1A10

1.02e-049392CID000197602
DrugChebi:32663

UGT1A9 UGT1A10

1.02e-049392CID005460873
Drug3-iodophenol

UGT1A9 UGT1A10

1.02e-049392CID000012272
DrugAC1L4J7U

UGT1A9 UGT1A10

1.02e-049392CID000186631
Drugkaempferol

CCN5 UGT1A9 MUC5AC UGT1A10

1.21e-04149394ctd:C006552
Drugcannabigerol

CNR2 ICAM3

1.28e-0410392CID005315659
Drug2,6-dihydroxyanthraquinone

UGT1A9 UGT1A10

1.28e-0410392ctd:C034889
DrugGlucuronides

UGT1A9 UGT1A10

1.28e-0410392ctd:D020719
Drug4-nitrophenyl)imidazole

UGT1A9 UGT1A10

1.56e-0411392CID000123155
DrugAC1O5XMV

UGT1A9 UGT1A10

1.56e-0411392CID006442661
DrugN-OH-DABZ

UGT1A9 UGT1A10

1.87e-0412392CID000051366
Drug1-O-beta-D-glucopyranosyl-D-mannitol

UGT1A9 UGT1A10

1.87e-0412392CID000088735
Drug7,7,7-triphenylheptanoic acid

UGT1A9 UGT1A10

1.87e-0412392CID000276709
Drugnonanoyl-N-methylglucamide

UGT1A9 UGT1A10

1.87e-0412392CID000160090
Drug4-hydroxyestrone

UGT1A9 UGT1A10

1.87e-0412392ctd:C026418
Drug2,4,6-TCB

UGT1A9 UGT1A10

1.87e-0412392CID000037247
DrugAC1MRGT8

UGT1A9 UGT1A10 CNR2

2.06e-0467393CID003517815
Drug2-hydroxyestrone

UGT1A9 UGT1A10

2.20e-0413392ctd:C024980
Drugcotinine-N-glucuronide

UGT1A9 UGT1A10

2.20e-0413392CID000000411
Drugtritanol

UGT1A9 UGT1A10

2.20e-0413392CID000006457
Drug5-azido-UDP-glucuronic acid

UGT1A9 UGT1A10

2.20e-0413392CID003081279
Drugalizarin

UGT1A9 UGT1A10

2.20e-0413392ctd:C010078
Drugpropranolol glucuronide

UGT1A9 UGT1A10

2.57e-0414392CID000119515
DrugPCB-61

UGT1A9 UGT1A10

2.57e-0414392CID000036401
Drugeugenol

UGT1A9 UGT1A10 CNR2

2.66e-0473393CID000003314
Drugsulforaphane nitrile

UGT1A9 UGT1A10

2.96e-0415392CID000543743
Drug2,2',3,5,5'-pentachlorobiphenyl

UGT1A9 UGT1A10

2.96e-0415392CID000040469
Drugcoumarin-3-carboxylic acid

UGT1A9 UGT1A10

2.96e-0415392CID000010752
DrugC11998

MUC5AC CNR2

2.96e-0415392CID005282036
Drugafloqualone

UGT1A9 UGT1A10

2.96e-0415392CID000002040
Drugbergamottin

UGT1A9 UGT1A10

2.96e-0415392ctd:C068337
Drugnaphthyl sulphate

UGT1A9 UGT1A10

2.96e-0415392CID000114775
Drug8-azaguanine

UGT1A9 UGT1A10 ICAM3

3.23e-0478393CID000008646
DrugPF-00562151-00 [351320-12-2]; Up 200; 10uM; PC3; HT_HG-U133A

ADGRB2 GPR137 MUC5AC ARHGEF10L

3.26e-041933945922_UP
Drugquercetin-3,4'-diglucoside

UGT1A9 UGT1A10

3.38e-0416392CID005320835
Drug1'-hydroxyestragole

UGT1A9 UGT1A10

3.38e-0416392CID000040003
Drugbilirubin-phosphate

UGT1A9 UGT1A10

3.38e-0416392CID005497144
DrugPF-00539758-00 [351321-34-1]; Up 200; 10uM; PC3; HT_HG-U133A

ADGRB2 LRP1 MUC5AC SVEP1

3.39e-041953946379_UP
DrugDihydrostreptomycin sulfate [5490-27-7]; Down 200; 2.8uM; PC3; HT_HG-U133A

GPR137 CHD3 SVEP1 ARHGEF10L

3.46e-041963945751_DN
Drug17-AAG; Down 200; 1uM; PC3; HG-U133A

GPR137 AHDC1 ARHGEF10L STAB1

3.46e-04196394432_DN
DrugParomomycin sulfate [1263-89-4]; Up 200; 5.6uM; MCF7; HT_HG-U133A

CHD3 MUC5AC SVEP1 CNR2

3.60e-041983943356_UP
DrugOxaprozin [21256-18-8]; Up 200; 13.6uM; PC3; HT_HG-U133A

ADGRB2 LRP1 MUC5AC SVEP1

3.60e-041983944530_UP
Drugvaldecoxib; Down 200; 10uM; MCF7; HT_HG-U133A

ADGRB2 GPR137 MUC5AC STAB1

3.67e-041993946403_DN
DrugLY 294002; Up 200; 0.1uM; PC3; HT_HG-U133A

GPR137 LRP1 ARSL CNR2

3.74e-042003944440_UP
Drug3 beta,5 alpha,25R)- 3-hydroxyspirostan-12-one

UGT1A9 UGT1A10

3.83e-0417392CID000003573
Drug6-hydroxychrysene

UGT1A9 UGT1A10

3.83e-0417392CID000037766
DrugSureCN12722713

UGT1A9 UGT1A10

4.30e-0418392CID005488034
Drug2,3,7-trichlorodibenzo-p-dioxin

UGT1A9 UGT1A10

4.30e-0418392CID000036614
DrugApApG

UGT1A9 UGT1A10

4.30e-0418392CID003081975
DrugC1 11-32

UGT1A9 UGT1A10

4.30e-0418392CID000443077
DrugC11131

UGT1A9 UGT1A10

4.30e-0418392CID000443076
Drugethyl-beta-D-6-glucosiduronic acid

UGT1A9 UGT1A10

4.30e-0418392CID000152226
DrugBr 2

UGT1A9 UGT1A10

4.30e-0418392CID003060900
Drugmenthol

UGT1A9 UGT1A10 CNR2

4.46e-0487393CID000001254
Drugalmokalant

UGT1A9 UGT1A10

4.80e-0419392CID003033962
Drug9-OH-risperidone

UGT1A9 UGT1A10

4.80e-0419392CID000475100
Drug5alpha-spirostan-3beta-ol

UGT1A9 UGT1A10

4.80e-0419392CID000091433
DrugHypochlorous Acid

LRP1 CHD3 SERINC1 ESCO1 CDCA7L

4.95e-04387395ctd:D006997
Drugtectochrysin

UGT1A9 UGT1A10

5.33e-0420392CID005281954
DrugAC1L1OBF

UGT1A9 UGT1A10

5.33e-0420392CID000032736
Drugentacapone

UGT1A9 UGT1A10

5.33e-0420392ctd:C071192
Drug4'-hydroxydiclofenac

UGT1A9 UGT1A10

5.33e-0420392CID000116545
Drugestriol-16-glucuronide

UGT1A9 UGT1A10

5.88e-0421392CID000122281
Drugdulcin

UGT1A9 UGT1A10

5.88e-0421392CID000009013
DrugBenzamidoxime hydrochloride

UGT1A9 UGT1A10

5.88e-0421392CID000069186
Drugplumbagin

UGT1A9 UGT1A10

6.46e-0422392ctd:C014758
DrugN-methylpiperazine

UGT1A9 UGT1A10

6.46e-0422392CID000053167
DrugEtodolac

UGT1A9 UGT1A10

6.46e-0422392ctd:D017308
Drugamonafide

UGT1A9 UGT1A10

6.46e-0422392CID000050515
Drugamidoxime

UGT1A9 UGT1A10

7.07e-0423392CID000465967
Drugestradiol-3-glucuronide

UGT1A9 UGT1A10

7.07e-0423392CID000066651
Drugphenanthridine

UGT1A9 UGT1A10

7.07e-0423392CID000009189
Diseaseblood 4-oxo-retinoic acid measurement

UGT1A9 UGT1A10

5.65e-063412EFO_0022216
Diseaseindole-3-carboxylate measurement

UGT1A9 UGT1A10

5.65e-063412EFO_0800043
DiseaseN-acetyl-4-chlorophenylalanine measurement

UGT1A9 UGT1A10

1.88e-055412EFO_0801060
Disease5-hydroxyindole sulfate measurement

UGT1A9 UGT1A10

1.88e-055412EFO_0800085
Diseasenuclear receptor subfamily 1 group D member 2 measurement

UGT1A9 UGT1A10

1.88e-055412EFO_0801853
Disease3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) measurement

UGT1A9 UGT1A10

2.82e-056412EFO_0800566
DiseaseX-21339 measurement

UGT1A9 UGT1A10

3.94e-057412EFO_0800808
DiseaseX-11793--oxidized bilirubin measurement

UGT1A9 UGT1A10

5.25e-058412EFO_0021260
DiseaseSuccinimide measurement

UGT1A9 UGT1A10

5.25e-058412EFO_0022118
DiseaseX-24849 measurement

UGT1A9 UGT1A10

5.25e-058412EFO_0800909
DiseaseX-11530 measurement

UGT1A9 UGT1A10

5.25e-058412EFO_0021249
Diseasesulfate of piperine metabolite C16H19NO3 (2) measurement

UGT1A9 UGT1A10

5.25e-058412EFO_0801034
Diseasecholelithiasis, bilirubin measurement

UGT1A9 UGT1A10

5.25e-058412EFO_0004570, EFO_0004799
DiseaseX-11522 measurement

UGT1A9 UGT1A10

5.25e-058412EFO_0800696
DiseaseX-10458 measurement

UGT1A9 UGT1A10

5.25e-058412EFO_0800692
Diseaseserum N-desmethylclozapine measurement

UGT1A9 UGT1A10

5.25e-058412EFO_0600043
Diseaseplasma clozapine measurement

UGT1A9 UGT1A10

5.25e-058412EFO_0600038
Diseasemembrane-associated progesterone receptor component 1 measurement

UGT1A9 UGT1A10

5.25e-058412EFO_0802740
DiseaseX-16946 measurement

UGT1A9 UGT1A10

5.25e-058412EFO_0800766
DiseaseX-11442 measurement

UGT1A9 UGT1A10

6.74e-059412EFO_0021236
DiseaseX-11441 measurement

UGT1A9 UGT1A10

6.74e-059412EFO_0021235
Diseasecirculating cell free DNA measurement

UGT1A9 UGT1A10

6.74e-059412EFO_0004739
Diseasetestis-specific chromodomain protein Y 1 measurement

UGT1A9 UGT1A10

6.74e-059412EFO_0802127
Diseasesulfate of piperine metabolite C18H21NO3 (3) measurement

UGT1A9 UGT1A10

6.74e-059412EFO_0801037
Diseasesulfate of piperine metabolite C18H21NO3 (1) measurement

UGT1A9 UGT1A10

6.74e-059412EFO_0801036
Diseasebilirubin measurement, response to xenobiotic stimulus

UGT1A9 UGT1A10

6.74e-059412EFO_0004570, GO_0009410
DiseaseX-11880 measurement

UGT1A9 UGT1A10

6.74e-059412EFO_0800698
Diseaseprotein-tyrosine kinase 6 measurement

UGT1A9 UGT1A10

6.74e-059412EFO_0020691
Diseaseindoleacetate measurement

UGT1A9 UGT1A10

8.42e-0510412EFO_0021015
DiseaseX-21448 measurement

UGT1A9 UGT1A10

8.42e-0510412EFO_0800816
DiseaseUDP-glucuronosyltransferase 1-6 measurement

UGT1A9 UGT1A10

8.42e-0510412EFO_0802185
Diseasebilirubin measurement, response to tenofovir

UGT1A9 UGT1A10

8.42e-0510412EFO_0004570, EFO_0009279
DiseaseX-23974 measurement

UGT1A9 UGT1A10

8.42e-0510412EFO_0800867
Diseasepregnenetriol sulfate measurement

UGT1A9 UGT1A10

1.03e-0411412EFO_0800586
Diseaseplasma N-desmethylclozapine measurement

UGT1A9 UGT1A10

1.03e-0411412EFO_0600039
Diseaseinsomnia, bilirubin measurement

UGT1A9 UGT1A10

1.03e-0411412EFO_0004570, EFO_0004698
Diseasehistidine betaine (hercynine) measurement

UGT1A9 UGT1A10

1.03e-0411412EFO_0800972
Diseasealdosterone measurement

UGT1A9 UGT1A10

1.03e-0411412EFO_0010219
DiseaseX-21796 measurement

UGT1A9 UGT1A10

1.03e-0411412EFO_0800825
Diseasebiliverdin measurement

UGT1A9 UGT1A10

1.23e-0412412EFO_0021033
Diseasep-cresol glucuronide measurement

UGT1A9 UGT1A10

1.23e-0412412EFO_0800079
Diseaseretinol dehydrogenase 16 measurement

UGT1A9 UGT1A10

1.46e-0413412EFO_0802007
Diseasepregnenetriol disulfate measurement

UGT1A9 UGT1A10

1.46e-0413412EFO_0800587
DiseaseX-24588 measurement

UGT1A9 UGT1A10

1.46e-0413412EFO_0800898
DiseaseCalcium channel blocker use measurement

ZNF831 AHDC1 SVEP1 ABHD17C

2.17e-04213414EFO_0009930
DiseaseX-21441 measurement

UGT1A9 UGT1A10

2.53e-0417412EFO_0800814
Diseaselow density lipoprotein cholesterol measurement, body fat percentage

UGT1A9 UGT1A10

2.53e-0417412EFO_0004611, EFO_0007800
Diseaseangiopoietin-related protein 1 measurement

UGT1A9 UGT1A10

2.84e-0418412EFO_0801382
Diseasetissue factor measurement

UGT1A9 UGT1A10

3.89e-0421412EFO_0010623
Diseasegallstones

UGT1A9 MUC5AC UGT1A10

4.59e-04108413EFO_0004210
Diseaseneuroblastoma, cutaneous melanoma

UGT1A9 UGT1A10

6.96e-0428412EFO_0000389, EFO_0000621
Diseasexanthurenate measurement

UGT1A9 UGT1A10

7.47e-0429412EFO_0010551
Diseaseresponse to dolutegravir

UGT1A9 UGT1A10

7.99e-0430412EFO_0600017
Diseasefear of minor pain measurement

TMEM65 GPR137

8.54e-0431412EFO_0008340
DiseaseAgents acting on the renin-angiotensin system use measurement

ZNF831 SVEP1 TRIM51G ABHD17C

1.19e-03335414EFO_0009931
Diseasevitamin D deficiency

UGT1A9 UGT1A10

1.22e-0337412EFO_0003762
Diseasecryptic phenotype measurement

ZNF831 ABHD17C

1.96e-0347412EFO_0021487
Diseasevitamin D measurement, COVID-19

UGT1A9 UGT1A10

2.13e-0349412EFO_0004631, MONDO_0100096

Protein segments in the cluster

PeptideGeneStartEntry
RCPWASLLLPCSACG

ADGRB2

1121

O60241
APFWCPILACCIPAF

ARHGEF10L

776

Q9HCE6
WRPWLQPCCGPFPLC

ARSL

566

P51690
PNGEWLCPRCTCPPL

CHD5

451

Q8TDI0
SQCAGRCSPPRCWTP

AHDC1

626

Q5TGY3
RWVPGICLPRCLCPA

C1orf147

91

Q96MC9
LCTSTPVWSLQRPPC

CCDC14

256

Q49A88
GWTCCPRPCSELFPL

CNR2

171

P34972
RRPCACCCPASWPST

H2BC20P

96

Q6DN03
CCCPASWPSTPCPRA

H2BC20P

101

Q6DN03
RRPCACCCPASWPST

H2BC19P

96

Q6DRA6
CCCPASWPSTPCPRA

H2BC19P

101

Q6DRA6
LWPAPCCSCHSELVP

GPR137

401

Q96N19
CPLCRVPLAHWACLP

KIF12

506

Q96FN5
CEWLCLLSPSGPVCT

LRP1

4156

Q07954
LCVSWRTPSICPLFC

MUC5AC

1151

P98088
LLDPDWVCPPCRGIC

CDCA7L

396

Q96GN5
LTCTGAPWPCRLLLP

PGAP6

256

Q9HCN3
PRACWTLLVCCLLTP

ICAM3

11

P32942
GRPCASSCLQCPWLT

OBSCN

7911

Q5VST9
GRWICDCCQRAPPTP

PHF10

471

Q8WUB8
GWCLPGLPCPSRCLC

PXDNL

16

A1KZ92
PLCWDECRGSCPTCP

FCGBP

1851

Q9Y6R7
PNGEWLCPRCTCPVL

CHD3

491

Q12873
VRTQLCPTPCTCPWP

CCN5

21

O76076
LCWLFCCPPCPSRIA

ABHD17C

16

Q6PCB6
CLPTICTASPCQPTW

KRTAP29-1

171

A8MX34
WCCSTLPEPAICGIS

ESCO1

756

Q5FWF5
IWAPLPCCSSELRPL

C3orf56

196

Q8N813
SKRRACWALLPPVPC

CRLS1

26

Q9UJA2
CWALLPPVPCCLGCL

CRLS1

31

Q9UJA2
PPVPCCLGCLAERWR

CRLS1

36

Q9UJA2
TWTSPPICRAVCRFP

SVEP1

3461

Q4LDE5
VPCTAARPLPSCWLC

SPRY3

156

O43610
ASWIPCLCGSAPCLL

SERINC1

11

Q9NRX5
LCLAWSPPCCGRPEQ

WDR90

1481

Q96KV7
WTSPVPLCVCLLLTC

UGT1A10

6

Q9HAW8
PGCRSWCLCPEVPSA

RHBDD2

6

Q6NTF9
LAAWGRCLCAVCPSP

WDFY4

2931

Q6ZS81
RAPNPCWPSPCSLLA

STAB1

231

Q9NY15
MACTGWTSPLPLCVC

UGT1A9

1

O60656
WTSPLPLCVCLLLTC

UGT1A9

6

O60656
SLWCCLSDPSIPGRC

UBE2Q2L

51

H0YL09
ACAQVPTSRAPLWPC

nan

176

Q6ZWC4
EVWLLACTRCFPTPP

RALGAPB

201

Q86X10
PRPPSWCCCGRGLLA

TMEM65

26

Q6PI78
NCSFSPPLWPIICCS

TRIM51G

436

A0A3B3IT33
RPPRTYHCPWCNICV

ZDHHC19

121

Q8WVZ1
LWVAPRCGCCSPLCP

ZNF295-AS1

46

Q8N0V1
PRLTWCCLSRSVPLP

ZNF831

1181

Q5JPB2